Responses
Clinical and epidemiological research
Extended report
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
Compose a Response to This Article
Other responses
No responses have been published for this article.